2022
DOI: 10.1111/cod.14068
|View full text |Cite
|
Sign up to set email alerts
|

Pattern of contact sensitization in patients with and without atopic dermatitis in an Asian dermatology center

Abstract: Background Although the traditional understanding is that contact sensitization is less frequent in patients with atopic dermatitis (AD), recent studies have shown similar or higher rates of positive patch‐test results in AD patients. Objectives We sought to characterise the pattern of contact sensitization in patients with and without AD and evaluate the association between AD and contact sensitization. Method This was a single‐center, 10‐year retrospective review of patients who underwent patch testing betwe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Most patients (80%) showed polysensitization to two or more steroid allergens, with the highest PPTRs for 0.1% budesonide and 0.1% betamethasone-17-valerate 33 . However, the most recent study by Wee et al 34 found that patients with AD were less likely to develop contact sensitization to budesonide. It is possible that the aforementioned result is attributable to the criteria of the AD group, which was established by the diagnostic code of AD-related diseases.…”
Section: Discussionmentioning
confidence: 97%
“…Most patients (80%) showed polysensitization to two or more steroid allergens, with the highest PPTRs for 0.1% budesonide and 0.1% betamethasone-17-valerate 33 . However, the most recent study by Wee et al 34 found that patients with AD were less likely to develop contact sensitization to budesonide. It is possible that the aforementioned result is attributable to the criteria of the AD group, which was established by the diagnostic code of AD-related diseases.…”
Section: Discussionmentioning
confidence: 97%